NO178496C - Kinolin-2-yl-metoksybenzylhydroksyurea - Google Patents

Kinolin-2-yl-metoksybenzylhydroksyurea

Info

Publication number
NO178496C
NO178496C NO922774A NO922774A NO178496C NO 178496 C NO178496 C NO 178496C NO 922774 A NO922774 A NO 922774A NO 922774 A NO922774 A NO 922774A NO 178496 C NO178496 C NO 178496C
Authority
NO
Norway
Prior art keywords
methoxybenzylhydroxyureas
quinolin
Prior art date
Application number
NO922774A
Other languages
English (en)
Norwegian (no)
Other versions
NO922774L (no
NO178496B (no
NO922774D0 (no
Inventor
Michael Matzke
Klaus-Helmut Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohlsdorfer
Reiner Muller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO922774D0 publication Critical patent/NO922774D0/no
Publication of NO922774L publication Critical patent/NO922774L/no
Publication of NO178496B publication Critical patent/NO178496B/no
Publication of NO178496C publication Critical patent/NO178496C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
NO922774A 1991-07-31 1992-07-14 Kinolin-2-yl-metoksybenzylhydroksyurea NO178496C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125270A DE4125270A1 (de) 1991-07-31 1991-07-31 Chinolin-2-yl-methoxybenzylhydroxyharnstoffe

Publications (4)

Publication Number Publication Date
NO922774D0 NO922774D0 (no) 1992-07-14
NO922774L NO922774L (no) 1993-02-01
NO178496B NO178496B (no) 1996-01-02
NO178496C true NO178496C (no) 1996-04-10

Family

ID=6437350

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922774A NO178496C (no) 1991-07-31 1992-07-14 Kinolin-2-yl-metoksybenzylhydroksyurea

Country Status (17)

Country Link
US (2) US5231103A (fr)
EP (1) EP0525571A1 (fr)
JP (1) JPH05201984A (fr)
KR (1) KR930002317A (fr)
AU (1) AU647640B2 (fr)
CA (1) CA2074788A1 (fr)
CZ (1) CZ281500B6 (fr)
DE (1) DE4125270A1 (fr)
FI (1) FI923422A (fr)
HU (1) HUT65252A (fr)
IE (1) IE922513A1 (fr)
IL (1) IL102666A0 (fr)
MX (1) MX9204239A (fr)
NO (1) NO178496C (fr)
RU (1) RU2048466C1 (fr)
TW (1) TW227996B (fr)
ZA (1) ZA925725B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
DE10236910A1 (de) * 2002-08-12 2004-03-11 Grünenthal GmbH Substituierte 1,2,3,4-Tetrahydrochinolinderivate
NO20093601A1 (no) 2009-12-29 2011-06-30 Idex Asa Overflatesensor
EP2543521B1 (fr) 2011-07-07 2015-09-23 European Central Bank Document de sécurité et procédé de protection d'un document de sécurité contre la falsification et pour l'authentification du document de sécurité

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334975C (fr) * 1987-11-13 1995-03-28 James H. Holms Composes inhibiteurs de type lipoxygenase contenant des groupes furane et pyrrole
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
PH30133A (en) * 1989-09-07 1997-01-21 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing lipoxygenase inhibiting compounds

Also Published As

Publication number Publication date
HU9202501D0 (en) 1992-10-28
KR930002317A (ko) 1993-02-22
CZ281500B6 (cs) 1996-10-16
AU2040192A (en) 1993-02-04
TW227996B (fr) 1994-08-11
CZ233692A3 (en) 1993-05-12
MX9204239A (es) 1993-05-01
FI923422A0 (fi) 1992-07-29
IE922513A1 (en) 1993-02-10
IL102666A0 (en) 1993-01-14
DE4125270A1 (de) 1993-02-04
US5231103A (en) 1993-07-27
FI923422A (fi) 1993-02-01
RU2048466C1 (ru) 1995-11-20
EP0525571A1 (fr) 1993-02-03
JPH05201984A (ja) 1993-08-10
NO922774L (no) 1993-02-01
ZA925725B (en) 1993-03-10
AU647640B2 (en) 1994-03-24
HUT65252A (en) 1994-05-02
NO178496B (no) 1996-01-02
NO922774D0 (no) 1992-07-14
US5399698A (en) 1995-03-21
CA2074788A1 (fr) 1993-02-01

Similar Documents

Publication Publication Date Title
DE69133396D1 (de) Warenauszahlsystem
DE69212332D1 (de) Farbball
DE59206583D1 (de) Windsichter
FI935297A0 (fi) Kinuklidinderivat
ATE137279T1 (de) Stoffauflauf
DE59209950D1 (de) Flaschendispenser
FI933697A0 (fi) 3-piperidinylmetylkarboxylatsubstituerade indoler
ATA131391A (de) Reibring
BR9204511A (pt) Recolhedor-enrolador
DE59208716D1 (de) Lymphoides cd30-antigen
FI924309A (fi) Skaermad rfi-genomfoering
DE69126968D1 (de) Tamburin
ATA170491A (de) Mauerstein
ATA39792A (de) Maehwerk
FI923422A (fi) Kinolin-2-yl-metoxibensylhydroxikarbamider
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
ATA9892A (de) Formstein
ATA67791A (de) Rollski
NO921872D0 (no) Kantbaandstyring
CA68725S (fr) Mobilier-jeu
BR9202017A (pt) Filatorio
BR9105539A (pt) Cover-matelasse hospitalar
BR7101338U (pt) Bule-chicara
BR7100738U (pt) Aerofolio
BR7100567U (pt) Auto-transponder